Barry D. Kerr

Four weeks administration of Liraglutide improves memory and learning as well as glycaemic control in mice with high fat dietary‐induced obesity and insulin resistance

David W. Porter, Barry D. Kerr, Peter R. Flatt et al. · Diabetes Obesity and Metabolism · 2010 · 150 citations

Medicine, Neuroscience, Pharmacology +15

Administration of an acylated GLP-1 and GIP preparation provides added beneficial glucose-lowering and insulinotropic actions over single incretins in mice with Type 2 diabetes and obesity

Victor A. Gault, Barry D. Kerr, Patrick Harriott et al. · Clinical Science · 2011 · 124 citations · Full text

Medicine, Endocrinology, Pharmacology +17

A novel GIP-oxyntomodulin hybrid peptide acting through GIP, glucagon and GLP-1 receptors exhibits weight reducing and anti-diabetic properties

Vikas K. Bhat, Barry D. Kerr, Peter R. Flatt et al. · Biochemical Pharmacology · 2013 · 75 citations

Medicine, Endocrinology, Pharmacology +16

A DPP-IV-resistant triple-acting agonist of GIP, GLP-1 and glucagon receptors with potent glucose-lowering and insulinotropic actions in high-fat-fed mice

Vineet Bhat, Barry D. Kerr, Srividya Vasu et al. · Diabetologia · 2013 · 65 citations

Medicine, Endocrinology, Pharmacology +17

(d-Ser2)Oxm[mPEG-PAL]: A novel chemically modified analogue of oxyntomodulin with antihyperglycaemic, insulinotropic and anorexigenic actions

Barry D. Kerr, Peter R. Flatt, Victor A. Gault · Biochemical Pharmacology · 2010 · 55 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +7